trending Market Intelligence /marketintelligence/en/news-insights/trending/wSStu4Pt-QBHHAKmizqtlA2 content esgSubNav
In This List

GlaxoSmithKline increases stake in Saudi Arabia unit

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


GlaxoSmithKline increases stake in Saudi Arabia unit

GlaxoSmithKline plc increased its stake in Glaxo Saudi Arabia Ltd. to 75% from 49%, Reuters reported.

The U.K.-based drugmaker raised its stake in its Saudi unit to benefit from Saudi Arabia's plan to boost local manufacturing of pharmaceutical products.

Further, the company also plans to inject over £180 million in its operations in the country over the next three years and expand production at its Jeddah, Saudi Arabia, manufacturing site by 30%.

The company said 80% of its portfolio is locally manufactured in Jeddah.